Search | IOVS | ARVO Journals

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Effects of an ALK-1 kinase inhibitor on ocular leakage and neovascularization in rats

Michael K Boettger; Andreas Schall; Thomas Schlange; Andreas Timmermann; Hannah Jörissen; Joachim Telser; Juergen Klar; Mario Lobell; Rolf Jautelat; Georges Von Degenfeld

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1115. doi:

ARVO Annual Meeting Abstract June 2015

Topically administered regorafenib eye drops inhibit grade IV lesions in the non-human primate laser CNV model

Michael Karl Boettger; Juergen Klar; Annett Richter; Georges von Degenfeld

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2294. doi:

ARVO Annual Meeting Abstract June 2015

Effects of the multi-kinase inhibitor regorafenib on ocular neovascularization

Juergen Klar; Michael Karl Boettger; Julia Freundlieb; Joerg Keldenich; Pierre-Paul Elena; Georges von Degenfeld

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):246. doi:

Advertisement